1. Home
  2. LSTA vs FEAM Comparison

LSTA vs FEAM Comparison

Compare LSTA & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • FEAM
  • Stock Information
  • Founded
  • LSTA 1980
  • FEAM 2016
  • Country
  • LSTA United States
  • FEAM United States
  • Employees
  • LSTA N/A
  • FEAM N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • FEAM Major Chemicals
  • Sector
  • LSTA Health Care
  • FEAM Industrials
  • Exchange
  • LSTA Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • LSTA 31.2M
  • FEAM 29.9M
  • IPO Year
  • LSTA N/A
  • FEAM N/A
  • Fundamental
  • Price
  • LSTA $2.51
  • FEAM $0.27
  • Analyst Decision
  • LSTA Strong Buy
  • FEAM Strong Buy
  • Analyst Count
  • LSTA 1
  • FEAM 2
  • Target Price
  • LSTA $15.00
  • FEAM $5.63
  • AVG Volume (30 Days)
  • LSTA 58.9K
  • FEAM 193.7K
  • Earning Date
  • LSTA 02-27-2025
  • FEAM 02-13-2025
  • Dividend Yield
  • LSTA N/A
  • FEAM N/A
  • EPS Growth
  • LSTA N/A
  • FEAM N/A
  • EPS
  • LSTA N/A
  • FEAM N/A
  • Revenue
  • LSTA N/A
  • FEAM N/A
  • Revenue This Year
  • LSTA N/A
  • FEAM N/A
  • Revenue Next Year
  • LSTA N/A
  • FEAM $200.00
  • P/E Ratio
  • LSTA N/A
  • FEAM N/A
  • Revenue Growth
  • LSTA N/A
  • FEAM N/A
  • 52 Week Low
  • LSTA $2.19
  • FEAM $0.26
  • 52 Week High
  • LSTA $4.20
  • FEAM $2.48
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 40.33
  • FEAM 33.28
  • Support Level
  • LSTA $2.51
  • FEAM $0.26
  • Resistance Level
  • LSTA $2.66
  • FEAM $0.47
  • Average True Range (ATR)
  • LSTA 0.19
  • FEAM 0.06
  • MACD
  • LSTA -0.01
  • FEAM -0.01
  • Stochastic Oscillator
  • LSTA 17.50
  • FEAM 5.09

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: